Manzanita Pharmaceuticals Inc Redwood City, CA - 94062

Manzanita Pharmaceuticals Inc is categorized under Medical Research in Redwood City, CA and active since 2007.

Manzanita Pharmaceuticals Inc was established in 2007, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 541720 by the NAICS.

If you are seeking more information, feel free to contact Constance Mckee at the company’s single location by writing to 2995 Woodside Road # 400, Redwood City, California CA 94062 or by phoning (408) 872-1094. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Manzanita Pharmaceuticals Inc
Contact Person: Constance Mckee
Address: 2995 Woodside Road # 400, Redwood City, California 94062
Phone Number: (408) 872-1094
Annual Revenue (USD): $500.000 to $999.999
Founded: 2007
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Medical Research
SIC Code: 8733
NAICS Code: 541720
Share This Business:

Manzanita Pharmaceuticals Inc was started in 2007 to provide professional Medical Research under the SIC code 8733 and NAICS code 541720. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Constance Mckee for inquiries that concern Manzanita Pharmaceuticals Inc by calling the company number (408) 872-1094, as your correspondence is most welcome. Additionally, the physical location of the single location of Manzanita Pharmaceuticals Inc can be found at the coordinates 37.429177,-122.253022 as well as the street address 2995 Woodside Road # 400 in Redwood City, California 94062.

For its online presence, you may visit Manzanita Pharmaceuticals Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.